Clinical features and prognosis in ocular toxoplasmosis
- PMID: 15295668
- DOI: 10.1007/s10384-003-0069-0
Clinical features and prognosis in ocular toxoplasmosis
Abstract
Purpose: To evaluate retrospectively the clinical characteristics, complications, and prognosis in patients with ocular toxoplasmosis.
Patients and methods: We reviewed the records of 189 patients (243 eyes) with ocular toxoplasmosis who were examined between 1972 and 1999. Color fundus photography and, in some patients, fluorescein angiography and indocyanine green angiography were performed. There were 98 male (52%) and 91 female (48%) patients with a mean age of 22.8 +/- 8.9 years.
Results: Of the patients, 140 (74%) had congenital and 49 (26%) had acquired toxoplasmosis. At the initial examination, there were active lesions in 65 eyes and inactive lesions in 178 eyes. Active lesions included retinochoroiditis in 59 (91%), papillitis in 2 (3%), and neuroretinitis in 4 (6%) eyes. There was also an inactive scar in 17 eyes with active retinochoroiditis. Localisation of the active retinochoroiditis was the macula in 44 (74%), the macula and peripheral retina in 3 (5%), the peripheral retina in 9 (15%) and the peripapillary retina in 3 (5%) eyes. Optic atrophy, pigment epithelial detachment, choroidal neovascularization, lamellar macular hole, and retinal neovascularization were seen during the follow-up period.
Conclusions: Ocular toxoplasmosis commonly affects the macula and seriously impairs visual acuity. The prevention of acquired and congenital infections is very important in controlling ocular toxoplasmosis. Patients should be followed to avoid late complications.
Copyright Japanese Ophthalmological Society 2004
Similar articles
-
Acute choroidal ischemia associated with toxoplasmic retinochoroiditis.Retina. 2007 Sep;27(7):947-51. doi: 10.1097/IAE.0b013e3180653d0d. Retina. 2007. PMID: 17891022
-
Optic nerve changes in ocular toxoplasmosis.Eye (Lond). 2007 Jun;21(6):746-51. doi: 10.1038/sj.eye.6702319. Epub 2006 Mar 31. Eye (Lond). 2007. PMID: 16575416
-
Fluorescein and indocyanine green angiography in ocular toxoplasmosis.Graefes Arch Clin Exp Ophthalmol. 2006 Dec;244(12):1688-91. doi: 10.1007/s00417-006-0345-z. Graefes Arch Clin Exp Ophthalmol. 2006. PMID: 16673136
-
Clinical manifestations of ocular toxoplasmosis in Yogyakarta, Indonesia: a clinical review of 173 cases.Southeast Asian J Trop Med Public Health. 2003 Jun;34(2):291-7. Southeast Asian J Trop Med Public Health. 2003. PMID: 12971552 Review.
-
[Toxoplasmosis and ocular pathology].Schweiz Med Wochenschr Suppl. 1995;65:82S-88S. Schweiz Med Wochenschr Suppl. 1995. PMID: 7716457 Review. French.
Cited by
-
Clinical manifestation and prognosis of active ocular toxoplasmosis in Iran.Int Ophthalmol. 2012 Dec;32(6):539-45. doi: 10.1007/s10792-012-9599-0. Epub 2012 Jun 26. Int Ophthalmol. 2012. PMID: 22733253
-
Clinical features and treatment of ocular toxoplasmosis.Korean J Parasitol. 2013 Aug;51(4):393-9. doi: 10.3347/kjp.2013.51.4.393. Epub 2013 Aug 30. Korean J Parasitol. 2013. PMID: 24039281 Free PMC article. Review.
-
Combination photodynamic therapy and bevacizumab for choroidal neovascularization associated with toxoplasmosis.Indian J Ophthalmol. 2011 Jan-Feb;59(1):62-4. doi: 10.4103/0301-4738.73728. Indian J Ophthalmol. 2011. PMID: 21157079 Free PMC article.
-
Toxoplasma Retinochoroiditis with Chorioretinal Neovascularization in a Young Patient.Case Rep Ophthalmol. 2021 Apr 16;12(1):259-263. doi: 10.1159/000512286. eCollection 2021 Jan-Apr. Case Rep Ophthalmol. 2021. PMID: 34054467 Free PMC article.
-
Intravitreal aflibercept for choroidal neovascularization associated with chorioretinitis: a pilot study.Clin Ophthalmol. 2017 Jul 20;11:1315-1320. doi: 10.2147/OPTH.S132923. eCollection 2017. Clin Ophthalmol. 2017. PMID: 28769551 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources